Mobile Phone Reminders (and Photovoice) for Routine Immunization in Nigeria - The MOPING Study

NCT03402646 | Unknown DMC

• 1 other identifier: MOPING/V2/07/17
• Study Type: interventional
• Target: 1,813
• Locations: 0 countries
• Sites: N/A

Brief Summary

This study aims to implement and test the efficacy of photovoice, Short Messaging Service (SMS) and phone call reminders in improving childhood immunization coverage (uptake, timeliness and completion rates) and reducing incidence of vaccine-preventable diseases (VPDs) among infants in Nigeria

Conditions

Immunization; Infection

Outcome Measures

Primary Outcomes (2)

• Immunization coverage

  Proportion of randomized infants who received birth doses of BCG and OPV (overall), and complete doses of each vaccine as scheduled

  12 months

• Timeliness of receipt of scheduled immunization

  Proportion of infants receiving scheduled immunization within 1 week of schedule

  12 months

Secondary Outcomes (1)

• Incidence of any childhood vaccine-preventable disease

  12 months

Study Arms (3)

Reminder module (SMS and Phone call)

EXPERIMENTAL

Intervention will consist of a "Reminder module" delivered via SMS and telephone calls by an automated, customized software application. This will include standardized SMS reminder 3 days prior to scheduled immunization clinic appointments, telephone call reminders a day prior to scheduled clinic appointment (4 to 6pm) (in addition to standard care - routine paper-based appointment scheduling and counselling by care providers) for routine immunization. Reminders will be provided consistently for all immunization clinic appointments until the child turns 12 months of age.

Behavioral: Reminder module (SMS and Phone call)

Photovoice

EXPERIMENTAL

In two small groups of 15 participants each per state, purposively selected pregnant women in their third trimester and parents of infants aged 0-12 months in the community, as well as community leaders, service providers and policy makers will be exposed to photographs (taken from other sources) of debilitating consequences of non-immunization, which will form the basis of the group discussions, knowledge sharing and consensus-building sessions, each lasting about 45 minutes to 1 hour. Each community cluster will be linked to a PHC.

Behavioral: Photovoice

Control

NO INTERVENTION

Respondents in control clusters will receive standard care only - comprising routine paper-based appointment scheduling

Interventions

Reminder module (SMS and Phone call) BEHAVIORAL

Same as described under arm/group descriptions

Reminder module (SMS and Phone call)

Photovoice BEHAVIORAL

Same as described under arm/group descriptions

Photovoice

Eligibility Criteria

• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Mothers/caregivers of healthy infants (age 0 - 12 months) who:
• Have a mobile phone access
• Received antenatal care and/or delivered their babies in a hospital
• Plans to receive immunizations at the selected PHCs
• Purposively-selected community sample of pregnant women in their third trimester, parents/caregivers of infants, providers, community gatekeepers and policy makers

You may not qualify if:

• Parents of infants requiring hospital admission due to significant illness, congenital deformity/malformation and prematurity
• Foreigners

Sponsors & Collaborators

• Universiti Putra Malaysia: lead
• RCSI & UCD Malaysia Campus: collaborator

Related Publications (1)

• Palmer MJ, Henschke N, Bergman H, Villanueva G, Maayan N, Tamrat T, Mehl GL, Glenton C, Lewin S, Fonhus MS, Free C. Targeted client communication via mobile devices for improving maternal, neonatal, and child health. Cochrane Database Syst Rev. 2020 Jul 14;8(8):CD013679. doi: 10.1002/14651858.CD013679.

  PMID: 32813276 DERIVED

MeSH Terms

Conditions

Infections

Interventions

Spermine Synthase

Intervention Hierarchy (Ancestors)

Alkyl and Aryl Transferases; Transferases; Enzymes; Enzymes and Coenzymes

Study Officials

• Surajudeen A Abdulrahman, MBBS, PhD

  RCSI & UCD Malaysia Campus

  PRINCIPAL INVESTIGATOR

• Niyi Osamiluyi

  Premier Medical Systems

  STUDY DIRECTOR

Central Study Contacts

Surajudeen A Abdulrahman, MBBS, PhD

CONTACT

+60167067760; abdulsuraj@gmail.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: INVESTIGATOR, OUTCOMES ASSESSOR
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Model Details: This will be a single-blind three-arm cluster randomized controlled trial involving post-partum mothers and/or caregivers of infants (age 0-12months) attending immunization clinics in 12 randomly selected Primary Health Care Centres (clusters) across Sokoto, Jigawa, Kano, Ogun, Oyo and Lagos States of Nigeria. Additionally, the investigators will be implementing a photovoice methodology in 6 community clusters (one in each State) involving group discussions between community members (pregnant women in their third trimester, parents/caregivers of infants age 0-12 months), community leaders, service providers and policy makers on benefits of timely immunization and consequences of non-vaccination.

Study Record Dates

• First Submitted: December 19, 2017
• First Posted: January 18, 2018
• Study Start: May 1, 2018
• Primary Completion: June 1, 2019
• Study Completion: December 1, 2019
• Last Updated: January 18, 2018

Record last verified: 2018-01